Search results for "Biological product"

showing 10 items of 126 documents

Novel Cancer Chemotherapy Hits by Molecular Topology: Dual Akt and Beta-Catenin Inhibitors

2015

Background and purposeColorectal and prostate cancers are two of the most common types and cause of a high rate of deaths worldwide. Therefore, any strategy to stop or at least slacken the development and progression of malignant cells is an important therapeutic choice. The aim of the present work is the identification of novel cancer chemotherapy agents. Nowadays, many different drug discovery approaches are available, but this paper focuses on Molecular Topology, which has already demonstrated its extraordinary efficacy in this field, particularly in the identification of new hit and lead compounds against cancer. This methodology uses the graph theoretical formalism to numerically chara…

Quantitative structure–activity relationshipCell SurvivalColorectal cancerScienceQuantitative Structure-Activity RelationshipAntineoplastic AgentsComputational biologyBiologyBioinformaticsProstate cancerCell Line TumorNeoplasmsDrug DiscoverymedicineHumansProtein Kinase InhibitorsProtein kinase Bbeta CateninPI3K/AKT/mTOR pathwayBiological ProductsMultidisciplinaryMolecular StructureDrug discoveryTOR Serine-Threonine KinasesQRBiological activitymedicine.diseaseMedicineTOR Serine-Threonine KinasesProto-Oncogene Proteins c-aktSignal TransductionResearch ArticlePLOS ONE
researchProduct

Modeling Natural Anti-Inflammatory Compounds by Molecular Topology

2011

One of the main pharmacological problems today in the treatment of chronic inflammation diseases consists of the fact that anti-inflammatory drugs usually exhibit side effects. The natural products offer a great hope in the identification of bioactive lead compounds and their development into drugs for treating inflammatory diseases. Computer-aided drug design has proved to be a very useful tool for discovering new drugs and, specifically, Molecular Topology has become a good technique for such a goal. A topological-mathematical model, obtained by linear discriminant analysis, has been developed for the search of new anti-inflammatory natural compounds. An external validation obtained with …

Quantitative structure–activity relationshiplinear discriminant analysismedicine.drug_classAnti-Inflammatory AgentsQuantitative Structure-Activity RelationshipComputational biologyCatalysisAnti-inflammatoryNatural (archaeology)ArticleModel validationInorganic Chemistrylcsh:ChemistrymedicinePhysical and Theoretical ChemistryMolecular Biologylcsh:QH301-705.5Spectroscopynaturalanti-inflammatoryVirtual screeningBiological ProductsChemistryOrganic ChemistryExternal validationGeneral MedicineMolecular Topologyvirtual screeningCombinatorial chemistryComputer Science Applicationslcsh:Biology (General)lcsh:QD1-999Models ChemicalMolecular Topology; virtual screening; natural; anti-inflammatory; linear discriminant analysisIdentification (biology)Molecular topologyInternational Journal of Molecular Sciences
researchProduct

The Deep-Sea Natural Products, Biogenic Polyphosphate (Bio-PolyP) and Biogenic Silica (Bio-Silica), as Biomimetic Scaffolds for Bone Tissue Engineeri…

2013

Bone defects in human, caused by fractures/nonunions or trauma, gain increasing impact and have become a medical challenge in the present-day aging population. Frequently, those fractures require surgical intervention which ideally relies on autografts or suboptimally on allografts. Therefore, it is pressing and likewise challenging to develop bone substitution materials to heal bone defects. During the differentiation of osteoblasts from their mesenchymal progenitor/stem cells and of osteoclasts from their hemopoietic precursor cells, a lineage-specific release of growth factors and a trans-lineage homeostatic cross-talk via signaling molecules take place. Hence, the major hurdle is to fab…

ScaffoldCell signalingOsteoclastsPharmaceutical Sciencebio-polyphosphateReview02 engineering and technologyscaffoldBone morphogenetic protein 2Bone and BonesExtracellular matrix03 medical and health sciencesOsteoprotegerinBiomimetic MaterialsPolyphosphatesBMP-2Drug DiscoveryMorphogenesisAnimalsHumansbone tissue engineeringPharmacology Toxicology and Pharmaceutics (miscellaneous)lcsh:QH301-705.5030304 developmental biologymorphogenetic scaffoldsBiological Products0303 health sciencesOsteoblastsTissue EngineeringTissue Scaffoldsbiologybio-silicaChemistryMesenchymal stem cellRANKLAnatomySilicon Dioxide021001 nanoscience & nanotechnologyCell biologylcsh:Biology (General)RANKLosteoprotegerinbiology.proteinStem cell0210 nano-technologyMarine Drugs
researchProduct

Psoriatic arthritis and COVID ‐19 pandemic: Consequences in medical treatment?

2020

The COVID‐19 pandemic has a strong negative impact on human society world‐wide. Patients with immune‐mediated disease may be prone to an increased risk of infection and/ or more severe course. We review the available data for patients with psoriatic arthritis (PSA) and systemic treatments. Current treatment options are summarized. Based upon the experience with COVID‐19 the following problems are addressed: (a) Can systemic treatment reduce comorbidities of PsA that are also comorbidities for COVID‐19? Does systemic medical treatment pose an increased risk of infection with SARS‐CoV‐2? Does systemic drug therapy have an impact on the risk of pulmonary fibrosis ‐ a factor with strong negativ…

Special Issue Articlesmedicine.medical_specialtyDiseaseComorbidityDermatologyPlacebo030207 dermatology & venereal diseases03 medical and health sciencesPsoriatic arthritisPsoriatic arthritis; systemic medical treatment0302 clinical medicinePharmacotherapyCOVID‐19Internal medicinePandemicmedicineHumansJanus Kinase InhibitorsbiologicsBiological Productsbusiness.industrySARS-CoV-2Tumor Necrosis Factor-alphaArthritis PsoriaticInterleukinSpecial Issue ArticleCOVID-19General Medicinemedicine.diseaseComorbiditysmall molecules030220 oncology & carcinogenesisAirwaybusinessDermatologic Therapy
researchProduct

Bioactive polyketides and alkaloids from Penicillium citrinum , a fungal endophyte isolated from Ocimum tenuiflorum

2013

Chemical investigation of the endophytic fungus Penicillium citrinum cultured on white beans or on rice led to the isolation of two new alkaloids (1 and 2), along with fourteen known polyketides (6-12, 14-20) and four known alkaloids (3-5, and 13). The structures of the isolated compounds were determined by extensive analysis of the 1D, 2D NMR, and MS data, and by comparison with the literature. Compound 13, which had been previously obtained only by chemical synthesis, was isolated as a natural product for the first time, while compound 6 was firstly reported as a fungal metabolite. A re-isolation of sclerotinin A (14) revealed it to be a diastereoisomeric mixture (14a and 14b), whose ster…

Staphylococcus aureusLymphomaStereochemistryAntineoplastic Agentsmedicine.disease_causeChemical synthesisEndophyteInhibitory Concentration 50Micechemistry.chemical_compoundAlkaloidsCell Line TumorDrug DiscoveryEndophytesmedicineAnimalsPenicillium citrinumCytotoxicityPharmacologyBiological ProductsNatural productMolecular StructurebiologyPenicilliumGeneral Medicinebiology.organism_classificationOcimumAnti-Bacterial AgentsOcimumchemistryStaphylococcus aureusPolyketidesAntibacterial activityFitoterapia
researchProduct

Acylated oleanane-type saponins from Ganophyllum giganteum

2014

Abstract Five oleanane-type saponins , 3- O -β- D -glucuronopyranosylzanhic acid 28- O -β- D -xylopyranosyl-(1→3)-[α- L -rhamnopyranosyl-(1→2)]-(4- O -acetyl)-β- D -fucopyranosyl ester ( 1 ), 3- O -β- D -glucopyranosylzanhic acid 28- O -β- D -xylopyranosyl-(1→3)-[α- L -rhamnopyranosyl-(1→2)]-(4- O -acetyl)-β- D -fucopyranosyl ester ( 2 ), zanhic acid 28- O -β- D -xylopyranosyl-(1→3)-[α- L -rhamnopyranosyl-(1→2)]-(4- O -acetyl)-β- D -fucopyranosyl ester ( 3 ), zanhic acid 28- O -α- L -rhamnopyranosyl-(1→2)-4- O -[(3′-hydroxy-2′-methyl-butyroyloxy)-3-hydroxy-2-methyl-butyroyloxy]-β- D -fucopyranosyl ester ( 4 ), medicagenic acid 28- O -α- L -rhamnopyranosyl-(1→2)-4- O -[(3′-hydroxy-2′-methyl-…

StereochemistryAcylationMolecular ConformationPlant ScienceHorticulturePlant RootsBiochemistryMiceStructure-Activity Relationshipchemistry.chemical_compoundSapindaceaeCell Line TumorAnimalsHumansOrganic chemistryMoietyOleanolic AcidMolecular BiologyOleananeCell ProliferationInflammationBiological ProductsDose-Response Relationship DrugChemistryHydrolysisAnti-Inflammatory Agents Non-SteroidalGeneral MedicineSaponinsAntineoplastic Agents PhytogenicMedicagenic acidDoratoxyleaeDrug Screening Assays AntitumorPhytochemistry
researchProduct

Beyond Pseudo‐natural Products: Sequential Ugi/Pictet‐Spengler Reactions Leading to Steroidal Pyrazinoisoquinolines That Trigger Caspase‐Independent …

2021

In this work, we describe how stereochemically complex polycyclic compounds can be generated by applying a synthetic sequence comprising an intramolecular Ugi reaction followed by a Pictet-Spengler cyclization on steroid-derived scaffolds. The resulting compounds, which combine a fragment derived from a natural product and a scaffold not found in nature. are both structurally distinct and globally similar to natural products at the same time, and interrogate an alternative region of the chemical space. One of the new compounds showed significant antiproliferative activity on HepG2 cells through a caspase-independent cell-death mechanism, an appealing feature when new antitumor compounds are…

StereochemistryAntineoplastic AgentsSequence (biology)01 natural sciencesBiochemistryPiperazineschemistry.chemical_compoundDrug DiscoveryHumansGeneral Pharmacology Toxicology and PharmaceuticsCell ProliferationPharmacologyBiological ProductsNatural productPictet–Spengler reactionCell DeathMolecular Structure010405 organic chemistryOrganic ChemistryCaspase independentStereoisomerismHep G2 CellsIsoquinolinesChemical space0104 chemical sciences010404 medicinal & biomolecular chemistrychemistryCaspasesIntramolecular forceHepg2 cellsMolecular MedicineUgi reactionSteroidsDrug Screening Assays AntitumorChemMedChem
researchProduct

Cytotoxic activity of some natural and syntetic sesquiterpene lactones

2006

Several natural and synthetic sesquiterpene lactones with different skeletons were tested and found to be active against nine cancer cell lines. Elemane (4), heliangolane (5) and their hydroxy analogues 9 and 10, all containing an α,β-unsaturated aldehyde substituent, were the most potent compounds.

StereochemistrySubstituentPharmaceutical ScienceCentaureaPharmacognosySesquiterpeneAldehydeANTITUMOR AGENTSAnalytical Chemistrychemistry.chemical_compoundInhibitory Concentration 50LactonesStructure-Activity RelationshipCell Line TumorDrug DiscoveryStructure–activity relationshipOrganic chemistryCytotoxic T cellHumansCENTAUREA-PAUICytotoxicityPharmacologychemistry.chemical_classificationBiological ProductsMolecular StructureDERIVATIVESOrganic ChemistryCNICINSettore CHIM/06 - Chimica OrganicaAntineoplastic Agents PhytogenicComplementary and alternative medicinechemistryMolecular MedicineSesquiterpenesLactone
researchProduct

Acid- and Base-Catalysis in the Mononuclear Rearrangement of Some (Z)-arylhydrazones of 5-Amino-3-benzoyl-1,2,4-oxadiazole in Toluene: Effect of Subs…

2011

The reaction rates for the rearrangement of eleven (Z)-arylhydrazones of 5-amino-3-benzoyl-1,2,4-oxadiazole 3a-k into the relevant (2-aryl-5-phenyl-2H-1, 2,3-triazol-4-yl)ureas 4a-k in the presence of trichloroacetic acid or of piperidine have been determined in toluene at 313.1 K. The results have been related to the effect of the aryl substituent by using Hammett and/or Ingold-Yukawa-Tsuno correlations and have been compared with those previously collected in a protic polar solvent (dioxane/water) as well as with those on the analogous rearrangement of the corresponding (Z)-arylhydrazones of 3-benzoyl-5-phenyl-1,2,4-oxadiazole 1a-k in benzene. Some light can thus be shed on the general di…

SubstituentOxadiazoleAlkaliesMedicinal chemistryCatalysisDioxanesStructure-Activity RelationshipAcid catalysischemistry.chemical_compoundPiperidinesUreaOrganic chemistryAminesTrichloroacetic AcidBenzeneBiological ProductsOxadiazolesMolecular StructureArylMRH acid- and base-catalysis kinetic measurementsOrganic ChemistryHydrazonesTemperatureWaterSettore CHIM/06 - Chimica OrganicaTolueneSolventKineticschemistryMononuclear rearrangements of heterocycles; (Z)-Arylhydrazones; acid catalysis; base catalysis.PiperidineHydrophobic and Hydrophilic InteractionsToluene
researchProduct

S2k guideline for treatment of cutaneous lupus erythematosus - guided by the European Dermatology Forum (EDF) in cooperation with the European Academ…

2016

Cutaneous lupus erythematosus (CLE) is a rare inflammatory autoimmune disease with heterogeneous clinical manifestations. To date, no therapeutic agents have been licensed specifically for patients with this disease entity, and topical and systemic drugs are mostly used 'off-label'. The aim of the present guideline was to achieve a broad consensus on treatment strategies for patients with CLE by a European subcommittee, guided by the European Dermatology Forum (EDF) and supported by the European Academy of Dermatology and Venereology (EADV). In total, 16 European participants were included in this project and agreed on all recommendations. Topical corticosteroids remain the mainstay of trea…

Systemic diseasemedicine.medical_specialtyVenereologyConsensusCalcineurin InhibitorsDermatologyDapsone030207 dermatology & venereal diseases03 medical and health sciencesAntimalarialsRetinoids0302 clinical medicineAdrenal Cortex HormonesmedicineLupus Erythematosus CutaneousHumans610 Medicine & healthlupus erythematous cuteneous guidelines treatmentLenalidomideLenalidomide030203 arthritis & rheumatologyBiological ProductsLupus erythematosusbusiness.industryfungiGuidelineMycophenolic Acidmedicine.diseaseDermatologyThalidomideClinical trialThalidomideInfectious DiseasesMethotrexatePractice Guidelines as TopicbusinessDapsoneImmunosuppressive Agentsmedicine.drug
researchProduct